Phase 1 Trial for Patients With Advanced Hematologic Malignancies Undergoing Reduced Intensity Allogeneic HCT With a T-cell Depleted Graft With Infusion of Conventional T-cells and Regulatory T-cells
Arms / Cohorts
Experimental:Arm A2: Fully matched (8/8) related/unrelated donor transplantation
Accepting patients
Experimental:Arm A3: Fully (8/8) matched related/unrelated donor transplantation
Accepting patients
Experimental:Arm C2: 7/8 mismatched related/unrelated donor transplantation
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.